Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis

Visceral leishmaniasis (VL) persists as a major public health problem, and since the existing chemotherapy is far from satisfactory, development of an effective vaccine emerges as the most appropriate strategy for confronting VL. The development of an effective vaccine relies on the selection of the...

Full description

Saved in:
Bibliographic Details
Published in:Int J Nanomedicine
Main Authors: Margaroni, Maritsa, Agallou, Maria, Athanasiou, Evita, Kammona, Olga, Kiparissides, Costas, Gaitanaki, Catherine, Karagouni, Evdokia
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2017
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5574665/
https://ncbi.nlm.nih.gov/pubmed/28883727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S141069
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items